BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11

• 

  Isolere Bio, Inc.
• 

  Merakris Therapeutics
• 

  BioCytics
• 

  Locus Biosciences
• 

  Cosette Pharmaceuticals
• 

  NC Life Sciences Organization
• 

  Biocom
• 

  Layoffs

  Merck Abandons $1.3B R&D Center in London, Boots 125 Employees

  Claiming that the domestic market undervalues pharma innovation, Merck has decided to pull the plug on all of its R&D efforts in the U.K.

  September 11, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• 

  Duchenne muscular dystrophy

  Avidity Touts Functional Improvements for DMD Therapy, Clearing Way to FDA

  Analysts at BMO Capital Markets expect the lack of other exon-44-skiping therapies to facilitate a “smooth” approval process for Avidity’s del-zota.

  September 11, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Pain

  FDA Looks to Streamline Development of Non-Opioid Painkillers

  New draft guidelines suggest the FDA is open to exercising regulatory flexibility for non-opioid drugs being developed for chronic pain.

  September 11, 2025

   · 

  2 min read

   · 

  Tristan Manalac